ha14-1 and thapsigargin
ha14-1 has been researched along with thapsigargin in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Akl, H; Bultynck, G; De Smedt, H; Hoylaerts, M; Kauskot, A; Luyten, T; Monaco, G; Parys, JB; Vandecaetsbeek, I; Welkenhuyzen, K | 1 |
| Ferdek, PE; Gerasimenko, JV; Gerasimenko, OV; Jakubowska, MA; Nicolaou, P; Petersen, OH | 1 |
Other Studies
2 other study(ies) available for ha14-1 and thapsigargin
| Article | Year |
|---|---|
HA14-1, but not the BH3 mimetic ABT-737, causes Ca2+ dysregulation in platelets and human cell lines.
Topics: Apoptosis; Benzopyrans; Biphenyl Compounds; Blood Platelets; Calcium; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Enzyme Inhibitors; Flow Cytometry; HEK293 Cells; HeLa Cells; Humans; Inositol 1,4,5-Trisphosphate Receptors; Nitriles; Nitrophenols; Piperazines; Proto-Oncogene Proteins c-bcl-2; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Sulfonamides; Thapsigargin | 2013 |
BH3 mimetic-elicited Ca
Topics: Acinar Cells; Animals; Antineoplastic Agents; Apoptosis; bcl-2 Homologous Antagonist-Killer Protein; bcl-2-Associated X Protein; Benzamides; Benzopyrans; Calcium; Drug Resistance, Neoplasm; Male; Mice; Mice, Inbred C57BL; Nitriles; Oligopeptides; Pancreas; Peptide Fragments; Peptides; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Thapsigargin | 2017 |